"10.1371_journal.pone.0074125","plos one","2013-09-09T00:00:00Z","Thomas P K Breckel; Christiane M Thiel; Edward T Bullmore; Andrew Zalesky; Ameera X Patel; Carsten Giessing","Biological Psychology Lab, Department of Psychology, University of Oldenburg, Oldenburg, Germany; Brain Mapping Unit, Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; Clinical Unit Cambridge, GlaxoSmithKline, Addenbrookes Centre for Clinical Investigations, Cambridge, United Kingdom; Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, United Kingdom; National Neuroscience Facility, University of Melbourne, Melbourne, VIC, Australia","Conceived and designed the experiments: TB CT EB. Performed the experiments: TB. Analyzed the data: TB. Contributed reagents/materials/analysis tools: AZ AP CG. Wrote the paper: TB CG.","E.T. Bullmore is employed half-time by GlaxoSmithKline and half-time by the University of Cambridge, and is a stockholder of GSK. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The remaining authors declare no competing financial interests.",29,3,0,"2013","09","Thomas P K Breckel","TPKB",6,TRUE,3,1,1,2,TRUE,TRUE,FALSE,0,NA,FALSE
